Taken together, our results suggest that patients with elevated preoperative CEA are at high risk of developing early recurrence, both distant and local, after resection of rectal cancer, regardless of whether levels normalize postoperatively or not. The gene discussed is CEACAM5; the disease is rectal cancer.